sodium thiosulfate has been researched along with amifostine anhydrous in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (36.36) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hazlitt, RA; Min, J; Zuo, J | 1 |
DeGregorio, MW; Gandara, DR; Makuch, RW; Perez, EA; Wiebe, VJ | 1 |
Anand, AJ; Bashey, B | 1 |
Blakley, BW; Burgio, DL; Church, MW; Kaltenbach, JA | 1 |
Blakley, BW; Burgio, DL; Church, MW; Kaltenbach, JA; McCaslin, DL | 1 |
Alberts, DS; Bleyer, A | 1 |
Sullivan, MJ | 1 |
Meyer, AK; Young, NM | 1 |
Brock, P; Cabral, S; Freyer, DR; Knight, K; Reaman, G; Robinson, PD; Sung, L | 1 |
Navarro-Ruiz, NE | 1 |
7 review(s) available for sodium thiosulfate and amifostine anhydrous
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss.
Topics: Animals; Cisplatin; Drug Discovery; Hearing Loss; Humans | 2018 |
Cisplatin rescue therapy: experience with sodium thiosulfate, WR2721, and diethyldithiocarbamate.
Topics: Amifostine; Antidotes; Cisplatin; Ditiocarb; Drug Therapy, Combination; Humans; Kidney Diseases; Thiosulfates | 1990 |
Newer insights into cisplatin nephrotoxicity.
Topics: Amifostine; Animals; Cisplatin; Furosemide; Glutathione; Humans; Kidney Diseases; Male; Mannitol; Sodium Chloride; Thiosulfates | 1993 |
Auditory late effects of chemotherapy.
Topics: Adolescent; Adult; Age Factors; Amifostine; Animals; Antineoplastic Agents; Brain Neoplasms; Child; Cranial Irradiation; Dose-Response Relationship, Radiation; Hearing Disorders; Humans; Models, Animal; Organoplatinum Compounds; Radiation Injuries; Radiotherapy Dosage; Survivors; Thiosulfates; Time Factors; Vincristine; Young Adult | 2009 |
Interventions for cisplatin-induced hearing loss in children and adolescents with cancer.
Topics: Acetylcysteine; Adolescent; Amifostine; Anti-Inflammatory Agents; Antineoplastic Agents; Chelating Agents; Child; Cisplatin; Cytoprotection; Dexamethasone; Disulfiram; Ditiocarb; Humans; Neoplasms; Ototoxicity; Thiosulfates | 2019 |
Prevention of Platinum-Induced Hearing Loss in Children with Cancer.
Topics: Amifostine; Humans; Neoplasms; Ototoxicity; Platinum; Practice Guidelines as Topic; Thiosulfates | 2020 |
4 other study(ies) available for sodium thiosulfate and amifostine anhydrous
Article | Year |
---|---|
The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity.
Topics: Amifostine; Animals; Anti-Bacterial Agents; Antidotes; Antineoplastic Agents; Auditory Threshold; Cisplatin; Cochlea; Cricetinae; Ditiocarb; Drug Interactions; Electrophysiology; Evoked Potentials, Auditory, Brain Stem; Fosfomycin; Hair Cells, Auditory; Hearing Loss, Sensorineural; Injections, Intraperitoneal; Male; Mesocricetus; Microscopy, Electron, Scanning; Radiation-Protective Agents; Random Allocation; Thiosulfates | 1995 |
Comparison of five agents in protecting the cochlea against the ototoxic effects of cisplatin in the hamster.
Topics: Amifostine; Animals; Antidotes; Antineoplastic Agents; Antioxidants; Auditory Threshold; Cell Survival; Chelating Agents; Cisplatin; Cochlea; Cricetinae; Ditiocarb; Drug Combinations; Evoked Potentials, Auditory, Brain Stem; Fosfomycin; Hair Cells, Auditory, Inner; Hair Cells, Auditory, Outer; Mesocricetus; Microscopy, Electron, Scanning; Organ of Corti; Semicircular Canals; Thiosulfates | 1997 |
Re: Sodium thiosulfate in cisplatin overdose by Erdlenbruch B et al., Med Pediatr Oncol 2002;38:349-352.
Topics: Amifostine; Antineoplastic Agents; Chelating Agents; Chemical and Drug Induced Liver Injury; Cisplatin; DNA Adducts; Drug Overdose; Humans; Injections, Intravenous; Injections, Subcutaneous; Liver Diseases; Radiation-Protective Agents; Thiosulfates | 2003 |
Hepatoblastoma, cisplatin, and ototoxicity: good news on deaf ears.
Topics: Amifostine; Cisplatin; Clinical Trials as Topic; Hearing Loss; Hepatoblastoma; Humans; Infant; International Cooperation; Liver Neoplasms; Research Design; Thiosulfates; Treatment Outcome | 2009 |